Prestige Consumer Healthcare
PBH
#3922
Rank
A$4.51 B
Marketcap
A$91.76
Share price
-1.54%
Change (1 day)
-24.25%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): A$6.36

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is A$5.78. In 2024 the company made an earnings per share (EPS) of A$6.12 an increase over its 2023 EPS that were of A-$2.29.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$6.363.79%
2024A$6.12-367.08%
2023A-$2.29-138.33%
2022A$5.9811.7%
2021A$5.3513.6%
2020A$4.71-651.67%
2019A-$0.85-148.78%
2018A$1.75-83.29%
2017A$10.48437.23%
2016A$1.95-34.13%
2015A$2.9652.94%
2014A$1.94-8.11%
2013A$2.11
2011A$1.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$14.87 157.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
A$10.01 73.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.48 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$2.45-57.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.47 98.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
A$9.13 57.88%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
A$0.57-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.12-11.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
A-$42.18-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
A$1.74-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel